Recruiting AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. NCT06991114 Conditions Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +29 more Locations Artiva Investigational Site Tuscaloosa — Tuscaloosa, Alabama, United States Artiva Investigational Site Phoenix — Phoenix, Arizona, United States Artiva Investigational Site Tucson — Tucson, Arizona, United States Artiva Investigational Site Chula Vista — Chula Vista, California, United States View all 52 locations View more locations Show fewer locations Loading locations... View Trial Details
